We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$704M
AUM Growth
+$17.6M
Cap. Flow
+$17.6M
Cap. Flow %
2.5%
Top 10 Hldgs %
34.59%
Holding
228
New
17
Increased
78
Reduced
95
Closed
3

Top Buys

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$2.94M
2
PYPL icon
PayPal
PYPL
+$2.45M
3
NVO
Novo Nordisk
NVO
+$2.38M
4
ADI icon
Analog Devices
ADI
+$1.8M
5
ADNT icon
Adient
ADNT
+$1.65M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.63M
2
IPGP icon
IPG Photonics
IPGP
+$1.49M
3
PRGO icon
Perrigo
PRGO
+$1.24M
4
KR icon
Kroger
KR
+$1.05M
5
GILD icon
Gilead Sciences
GILD
+$990K

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Technology 19.56%
3 Industrials 16.26%
4 Consumer Staples 11.7%
5 Financials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.35T
$7.62M 1.08%
197,320
+12,220
+7% +$476K
MSFT icon
27
Microsoft
MSFT
$3.76T
$7.04M 1%
113,246
+957
+0.9% +$57.6K
MMM icon
28
3M
MMM
$93.9B
$6.95M 0.99%
46,578
+215
+0.5% +$31K
PYPL icon
29
PayPal
PYPL
$50.5B
$6.76M 0.96%
171,365
+60,874
+55% +$2.45M
HOLX
30
DELISTED
Hologic
HOLX
$6.76M 0.96%
168,404
+17,095
+11% +$660K
NVDA icon
31
NVIDIA
NVDA
$5.27T
$6.75M 0.96%
2,529,800
+244,440
+11% +$511K
ABT icon
32
Abbott
ABT
$188B
$6.58M 0.93%
171,340
+33,383
+24% +$1.32M
NXPI icon
33
NXP Semiconductors
NXPI
$58.9B
$6.57M 0.93%
67,043
-7,246
-10% -$720K
AFL icon
34
Aflac
AFL
$61.1B
$6.45M 0.92%
185,444
+7,276
+4% +$256K
GILD icon
35
Gilead Sciences
GILD
$165B
$6.09M 0.87%
85,087
-13,318
-14% -$990K
FTV icon
36
Fortive
FTV
$18.6B
$5.82M 0.83%
172,168
+17,967
+12% +$594K
VFC icon
37
VF Corp
VFC
$5.86B
$5.43M 0.77%
108,167
+5,360
+5% +$278K
CSCO icon
38
Cisco
CSCO
$483B
$5.26M 0.75%
174,221
+16,676
+11% +$508K
XOM icon
39
ExxonMobil
XOM
$657B
$4.87M 0.69%
53,898
-3,894
-7% -$340K
CLC
40
DELISTED
Clarcor
CLC
$4.73M 0.67%
57,373
-9,357
-14% -$660K
TEVA icon
41
Teva Pharmaceuticals
TEVA
$42.1B
$4.62M 0.66%
127,452
-40,826
-24% -$1.63M
GE icon
42
GE Aerospace
GE
$380B
$4.21M 0.6%
27,831
+1,315
+5% +$191K
UL icon
43
Unilever
UL
$135B
$3.8M 0.54%
83,054
+26,752
+48% +$1.25M
NVO
44
Novo Nordisk
NVO
$209B
$3.77M 0.54%
210,402
+131,378
+166% +$2.38M
SJM icon
45
J.M. Smucker
SJM
$12.6B
$3.55M 0.5%
27,698
+22,705
+455% +$2.94M
CMG icon
46
Chipotle Mexican Grill
CMG
$40.7B
$3.5M 0.5%
464,100
+128,700
+38% +$1.02M
FISV
47
Fiserv Inc
FISV
$27.8B
$3.26M 0.46%
61,386
+1,376
+2% +$70.7K
PEP icon
48
PepsiCo
PEP
$188B
$3.2M 0.45%
30,584
+265
+0.9% +$27.8K
TJX icon
49
TJX Companies
TJX
$175B
$3.15M 0.45%
83,984
+3,312
+4% +$125K
MRK icon
50
Merck
MRK
$323B
$3.05M 0.43%
54,270
+2,616
+5% +$153K
1
2
3 4 5

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Reynders McVeigh Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Reynders McVeigh Capital Management held 228 positions worth $704M, up 2.6% from $686M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management's Q4 2016 filing shows 17 new, 78 increased, 95 reduced and 3 closed positions. Its largest new stake was Adient: 31,202 shares worth $1.83M. The largest sale was Teva Pharmaceuticals, an estimated $1.63M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2016 buy was Adient: 31,202 shares worth $1.83M.
  • Reynders McVeigh Capital Management added most to J.M. Smucker in Q4 2016, an estimated $2.94M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2016 reduction was Teva Pharmaceuticals, cutting an estimated $1.63M.
  • Reynders McVeigh Capital Management fully exited Blackrock in Q4 2016, selling an estimated $275K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $704M portfolio in Q4 2016.
  • Reynders McVeigh Capital Management opened 17 new positions and closed 3 in Q4 2016.
  • Reynders McVeigh Capital Management's portfolio value rose 2.6% quarter-over-quarter to $704M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.